Open Terminal →

Analyses / SNOW

SNOW Snowflake Inc. As of Nov 19, 2026
$279.62

Strong revenue growth and a rebound off the 52-week low, offset by negative margins, extreme valuation, and heavy insider selling.

Setup: Growth recovery, valuation-constrained Confidence: low Horizon: 3m Risk: high Category: Growth
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals SNOW's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Revenue growth is 31.4% (5-year 51.2%), and the stock is about 61% of the way up its 52-week range after a low of 118.30. Management commentary and sell-side previews cited in the news payload point to a possible fiscal Q3 product revenue beat (Oppenheimer and Morgan Stanley headlines). Gross margin of 67.2% is high for software, so margin expansion could drive re-rating if operating losses narrow. Current ratio of 1.30 suggests adequate near-term liquidity. Price rose 2.4% on the day and cleared the prior close of 272.94.

▼ Bear Case

Operating margin is -31.8% and net margin is -28.4%, so the company is not yet profitable on a GAAP basis. Price-to-sales is 20.9x and price-to-book is 33.9x, leaving little room for execution misses. Insider activity shows 630 sell transactions against 51 buys, with 11.6M shares sold versus 6.3M bought. A news headline flags high stock-based compensation as a drag on the outlook. EV/EBITDA is negative (-74.3x) because EBITDA is negative, so cash-earnings valuation tools are not usable here.

Valuation

overvalued — score 20/100

Multiples are very high relative to current profitability. Growth is the main support for the premium.

Technical Levels

Support · $272.94 (Prior close) · $269.20 (Day low)

Resistance · $280.30 (Day high) · $384.56 (52-week high)

RSI: Unavailable (null in payload)

Financial Health

Score 60/100. Liquidity ratios look adequate. Leverage and coverage cannot be assessed from the payload, and the company is loss-making.

Catalysts

Fiscal Q3 product revenue reportDate not provided in payload; previews from Oppenheimer and Morgan Stanley are in the news feedhigh
Read-through from Datadog outlook and reactionRecent, per news headlinemedium
Stock-based compensation trend and dilution commentaryNext earnings or filingmedium

Risk Flags

P/E and forward P/E are null, so earnings-based valuation cannot be checked from this payload.
EBITDA is negative, making EV/EBITDA (enterprise value vs cash earnings) not meaningful.
Insider selling dominates: 630 sells vs 51 buys in the provided activity window.
Fundamentals, balance sheet, cash flow, and sentiment fields are null. Coverage is thin.
RSI is null, so the momentum reading is unavailable from this provider payload.
ROE, ROIC, debt-to-equity, and FCF per share are null, limiting capital efficiency checks.

See SNOW's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock SNOW free →

Recent News

More Analyses

SNOW FAQ

Is SNOW a buy right now?

Snowflake Inc.'s current read is a Growth recovery, valuation-constrained setup with low confidence over a 3m horizon. Valuation: overvalued. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is SNOW overvalued?

overvalued (valuation score 20/100). Multiples are very high relative to current profitability. Growth is the main support for the premium.

What are the risks of buying SNOW?

Operating margin is -31.8% and net margin is -28.4%, so the company is not yet profitable on a GAAP basis. Price-to-sales is 20.9x and price-to-book is 33.9x, leaving little room for execution misses. Insider activity shows 630 sell transactions against 51 buys, with 11.6M shares sold versus 6.3M bought. A news headline flags high stock-based compensation as a drag on the outlook. EV/EBITDA is negative (-74.3x) because EBITDA is negative, so cash-earnings valuation tools are not usable here.